Impact of PET/CT on Patient Management Plan
| Before PET/CT | After PET/CT | PET/CT impact | |||||
| Management plan | No. of patients | Management plan | No. of patients | High | Medium | Low | None |
| Observation | 1 | Surgery | 1 | 1 | 0 | 0 | 0 |
| Invasive biopsy | 28 | Invasive biopsy | 9 | 19 | 0 | 9 | 0 |
| Observation | 1 | ||||||
| Surgical | 9 | ||||||
| Radical RT* | 3 | ||||||
| Palliative† | 6 | ||||||
| Surgery | 80 | Surgery | 54 | 26 | 0 | 50 | 4 |
| Diagnostic (invasive biopsy) | 2 | ||||||
| Observation | 2 | ||||||
| Radical RT‡ | 8 | ||||||
| Radical RT, for both NSCLC and PET-detected pharynx cancer | 1 | ||||||
| Palliative§ | 13 | ||||||
| Radical RT | 49 | Radical RT as planned∥ | 19 | 23 | 7 | 18 | 1 |
| Radical CRT, field increased | 6 | ||||||
| Radical CRT, field decreased | 1 | ||||||
| Surgery | 4 | ||||||
| Induction chemotherapy, followed by surgery | 1 | ||||||
| Palliative chemotherapy or RT¶ | 18 | ||||||
| Palliative | 10 | Palliative chemotherapy or RT, as planned# | 8 | 2 | 2 | 6 | 0 |
| Palliative CRT, RT field increased | 2 | ||||||
| Total | 168 | 168 | 71 (42%) | 9 (5%) | 83 (49%) | 5 (3%) | |
↵* Radical RT no chemotherapy (n = 1), radical CRT (n = 2).
↵† Palliative chemotherapy and RT (n = 5), chemotherapy (n = 1).
↵‡ Radical RT alone (n = 1), radical CRT (n = 7).
↵§ Palliative chemotherapy and RT (n = 10), chemotherapy only (n = 2), expectant palliative (n = 1).
↵∥ Radical RT (n = 5), radical CRT (n = 14).
↵¶ Palliative chemotherapy and RT (n = 17).
↵# Palliative chemotherapy and RT (n = 5), chemotherapy only (n = 3).
CRT = chemotherapy and radiation therapy.